TYNDALL CAPITAL PARTNERS L P sold 6.3% of their position (49.99K shares) of TRAWS PHARMA, INC. on the open market
Open‑market sale worth $105.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/20/2019ACC: 0000905718-19-000781
10% Owner
Since Jun 2019
-49.99K
Net shares
Net seller
$105.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
49.99K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−49.99K
Price / share
$2.10
Trade value
$105.01K
% of position
6.3%
9/18/2019
795.45K→745.45K
Total
Net shares
−49.99K
Net value
-$105.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/18/2019 | S · Sale | −49.99K | $2.10 | $105.01K | 6.3% | 795.45K | 745.45K |
| Total | −49.99K | -$105.01K | ||||||
Derivative Transactions0
No derivative transactions reported